Orbimed Capital, Director, Shareholder: Compass Therapeutics CMPX Planned sale · Filed 25/04/09

Trade details

Type: Planned sale notice
Stock: Compass Therapeutics CMPX
Person: Orbimed CapitalDirector, Shareholder
Planned sale date: 25/04/09
Filed: 25/04/09

2.6% of shares outstanding to be sold

Compass Therapeutics trades, last 26 weeks

What else happened in Compass Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/10~25/05/09

Orbimed Capital's recent trades

Orbimed CapitalShareholder
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$1.4M
29,385 sh
$1.4M
Filed 06/22
Traded 06/22
Orbimed CapitalShareholder
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$80.3K
1,747 sh
$80.3K
Filed 06/22
Traded 06/22
Orbimed CapitalShareholder
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$433.9K
10,243 sh
$433.9K
Filed 06/15
Traded 06/15
Orbimed CapitalDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
Orbimed CapitalDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21

Orbimed Capital, Director — plans to sell 3,571,428 sh of Compass Therapeutics CMPX · $5.7M · around 04/09 | Whalegun